Linda Lam

Mechanisms of resistance to systemic therapy in metastatic castration-resistant prostate cancer222 trích dẫn
Cancer Treatment Reviews · 2017 · DOI

Phase 1/2 study of fractionated dose lutetium‐177–labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 ( 177 Lu‐J591) for metastatic castration‐resistant prostate cancer134 trích dẫn
Cancer · 2019 · DOI

Saturation of, and competition for entry into, the apical secretory pathway56 trích dẫn
Proceedings of the National Academy of Sciences · 2000 · DOI

Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia52 trích dẫn
Haematologica · 2018 · DOI

Metal Chelates as Reversible Stains for Detection of Electroblotted Proteins: Application to Protein Microsequencing and Immunoblotting40 trích dẫn
Analytical Biochemistry · 1994 · DOI

Differential cellular responses induced by dorsomorphin and LDN ‐193189 in chemotherapy‐sensitive and chemotherapy‐resistant human epithelial ovarian cancer cells37 trích dẫn
International Journal of Cancer · 2014 · DOI

Allogeneic Tcrα/β Deficient CAR T-Cells Targeting CD123 Prolong Overall Survival of AML Patient-Derived Xenografts18 trích dẫn
Blood · 2016 · DOI

LBA16 Giredestrant (GIRE), an oral selective oestrogen receptor (ER) antagonist and degrader, + everolimus (E) in patients (pts) with ER-positive, HER2-negative advanced breast cancer (ER+, HER2– aBC) previously treated with a CDK4/6 inhibitor (i): Primary results of the phase III evERA BC trial17 trích dẫn
Annals of Oncology · 2025 · DOI

Selection and characterization of antibody clones are critical for accurate flow cytometry-based monitoring of CD123 in acute myeloid leukemia14 trích dẫn
Leukemia & lymphoma/Leukemia and lymphoma · 2017 · DOI

Final results of 2-dose fractionation of ¹⁷⁷Lu-J591 for progressive metastatic castration-resistant prostate cancer (mCRPC).8 trích dẫn
Journal of Clinical Oncology · 2016 · DOI